Do you typically employ ECP in patients with CTCL as monotherapy, or in conjunction with other systemic, pharmacologic or immune-based treatments?

Do you typically employ ECP in patients with CTCL as monotherapy, or in conjunction with other systemic, pharmacologic or immune-based treatments?

Do you typically employ ECP in patients with CTCL as monotherapy, or in conjunction with other systemic, pharmacologic or immune-based treatments?

 


Created by

CMEducation Resources IQ&A Extracorporeal Photopheresis Intelligence Zone | The Multi-Specialty Perspective

Presenter

Julia Scarisbrick, MD

Julia Scarisbrick, MD

Dr. Julia Scarisbrick
Consultant Dermatologist & Cutaneous Lymphoma
Lead at the University Hospital
Birmingham, UK